AxoGen, Inc. (LECT) Announces Release Date of 2012 Second Quarter Results and Conference Call  
8/1/2012 10:25:31 AM

ALACHUA, Fla.--(BUSINESS WIRE)--AxoGen, Inc. (OTCBB: AXGN) a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced that it will release its financial results for the period ended June 30, 2012, after the close of U.S. financial markets on August 14, 2012. An accompanying conference call hosted by Karen Zaderej, Chief Executive Officer, and Greg Freitag, Chief Financial Officer, to discuss results will be held at 11:00 a.m. ET, on August 15, 2012.